The Douglas Institute offers its residents the opportunity to acquire a developmental perspective of the individual, from infancy through childhood, adolescence, adulthood and into old age.

Antoine Adamantidis, PhD, is interested in the underlying neural mechanism for wakefulness or vigilance states.

Reut Gruber examines the association between sleep and attention in children and adolescents and the genetics of sleep.

Aurélie Labbe is a biostatistician who specializes in statistical genetics and genetic epidemiology.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Ridha Joober developed a pharmaco-genetic profile of schizophrenia that may lead to earlier diagnosis and more effective treatment.

Véronique Bohbot investigates the neural correlates underlying visual and auditory spatial memory in normal and brain-damaged individuals.

Jorge Armony, PhD conducts research on how the brain detects danger stimuli and how it interacts with consciousness and memory.

The researchers exploring the “Schizophrenia and neurodevelopmental disorders” theme focus on the causes, course, treatment and prevention of: Schizophrenia and other psychotic disorders Attention deficit hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder and Gilles de la Tourette syndrome Autism (research and evaluation) In Canada, one in a hundred people will be diagnosed with schizophrenia while 3 to 5% of children have an attention deficit...